Helen Xu

Papers

Total Citations

H-Index

About

Dr. Helen Xu is a leading figure in the development of MRI-guided robotic interventions for prostate cancer diagnosis. Her research focuses on the critical intersection of medical robotics, image registration, and clinical accuracy in targeted biopsy systems. Dr. Xu’s most significant contributions stem from her pioneering work at the U.S. National Cancer Institute, where she led the quantitative evaluation of a novel robotic prostate biopsy system that has been in clinical use for over five years. Her landmark 2010 study, which has garnered 35 citations, established the foundational accuracy validation for this system. In this work, she introduced a sophisticated two-step rigid volume registration algorithm using mutual information to align pre- and post-needle insertion MRI images, dramatically improving targeting precision. Her subsequent 2013 analysis (24 citations) further refined these accuracy metrics. Collectively, her three most-cited papers have accumulated nearly 80 citations, cementing her reputation as a key innovator in image-guided robotic surgery. Dr. Xu’s rigorous validation methodology has set a new standard for clinical accuracy assessment, directly impacting the safety and efficacy of minimally invasive prostate biopsies worldwide.